News
-
-
PRESS RELEASE
Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S.
Pulsenmore receives FDA De Novo marketing authorization for home-use prenatal ultrasound, creating a new era of prenatal care in the U.S. The system enables remote physician-guided scans at home
